
|Videos|October 27, 2011
Dr. Scagliotti Gives 3 Important Lung Cancer Takeaway Points
Author(s)Giorgio V. Scagliotti, MD, PhD
Dr. Giorgio Scagliotti from the University of Turin Gives 3 Important Lung Cancer Takeaway Points
Advertisement
Giorgio V. Scagliotti, MD, PhD, head of the Thoracic Oncology Unit, Department of Clinical and Biological Sciences, University of Turin, San Luigi Hospital, Orbassano, Italy, explains 3 lung cancer topics that require more awareness and research to produce optimal results in the future.
- Regardless of the cost a connection between early lung cancer detection and lower mortality needs to be established.
- To ensure the best treatment and diagnosis physicians need to refer every new patient with lung cancer to a multidisciplinary clinic.
- Further genomic investigation is needed and can increase survival in at least 30% of patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
Orca-T With Reduced-Intensity Conditioning Yields Robust Efficacy in Hematologic Malignancies
4
TRX103 Tr1 Cell Therapy Shows Manageable Safety and Dose-Dependent Kinetics After HLA-Mismatched HCT in Hematologic Malignancies
5




































